| Start date | Site | Title | Topic |
---|
ML24200A183 | 21 August 2024 | | Interim Staff Guidance, NMSS-ISG-03, Guidance for Implementation of 10 CFR Part 35 Training and Experience Requirements | Brachytherapy |
ML24031A609 | 31 January 2024 | | FY2023 Nuclear Material Event Database (NMED) Annual Report | Deep Dose Equivalent Pandemic COVID-19 Brachytherapy Stolen Backfit Exit Sign Overexposure Reactive Inspection Basic Component |
ML24033A303 | 23 January 2024 | | Draft for ACMUI Review - Interim Staff Guidance NMSS-ISG- Guidance for the Implementation of 10 CFR Part 25 Training & Experience Requirements - Draft for Comment | |
ML23237B473 | 18 January 2024 | | NRC Staff Training on Occupational Dose Assessment - EPD Vs. TLD-OSL | |
ML23284A132 | 27 November 2023 | | OMB-3150-0010 - Final Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material 2023 | Brachytherapy |
ML23257A264 | 29 September 2023 | | Summary of August 29, 2023, Public Meeting on Regulatory Basis for Part 35 Rulemaking on Rb-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material | |
ML23240A718 | 29 August 2023 | | Slides - Public Meeting on Regulatory Basis for Rb-82 Generators, Emerging Medical Technologies, and Other Medical Use of Byproduct Material | Enforcement Discretion Brachytherapy |
ML23257A263 | 29 August 2023 | | Transcript for the August 29, 2023, Public Meeting on Regulatory Basis for Part 35 Rulemaking on Rb-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material | Enforcement Discretion Brachytherapy |
ML23241A914 | 23 August 2023 | | T180-13 Effective 2021-04-05 Highlighted | Incorporated by reference Condition Adverse to Quality Exclusive Use Depleted uranium |
ML23241A917 | 23 August 2023 | | T180-13 Effective 2022-11-02 Highlighted | Incorporated by reference Condition Adverse to Quality Exclusive Use Depleted uranium |
ML23198A203 | 20 July 2023 | | Public Meeting on Information Request-Draft Regulatory Guide 8061, July 20, 2023 | |
STC-23-049, Notification of Issuance for Public Comment of the Regulatory Basis for the Rulemaking to Establish Requirements for Rubidium-82 Generators | 11 July 2023 | | STC-23-049 Notification of Issuance for Public Comment of the Regulatory Basis for the Rulemaking to Establish Requirements for Rubidium-82 Generators | |
ML23137A012 | 5 June 2023 | | OMB-3150-0010 - Draft Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material (2023) | Brachytherapy |
ENS 56510 | 6 May 2023 15:30:00 | Ihc Health Services, Dba Intermount | Liquid Radioactive Contamination | |
ML23122A118 | 3 May 2023 | | Responses to ACMUI Comments on the Regulatory Basis for the Rulemaking to Establish Requirements for Rb-82 Generators and Emerging Medical Technologies | Brachytherapy |
ML21230A318 | 30 April 2023 | | DG 8061 (RG 8.39 Rev 2) Release of Patients Administered Radioactive Material | Brachytherapy Eye plaque |
ML24045A274 | 31 March 2023 | | G 2023 Rev 1-24 Final - Use of Radionuclides in the Healing Arts | License Renewal Brachytherapy |
ENS 56378 | 22 February 2023 00:00:00 | Utah Valley Regional Medical Center | Leaking Equipment | |
ENS 56330 | 31 January 2023 21:45:00 | Intermountain Medical Center | Liquid Radioactive Contamination | |
ML23005A166 | 5 December 2022 | | December 5, 2022, Summary of Meeting Advisory Committee on the Medical Uses of Isotopes (ACMUI) Fall 2022 | |
ML22334A102 | 5 December 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Fall 2022 Meeting Handout | High Radiation Area Decommissioning Funding Plan Brachytherapy TheraSphere |
ML22334A269 | 30 November 2022 | | Advisory Committee on the Medical Uses of Isotope (ACMUI) Fall 2022 Meeting Handout (Revised) | High Radiation Area Decommissioning Funding Plan Brachytherapy TheraSphere |
ML22304A049 | 31 October 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Agenda December 5-6, 2022 | |
ML22223A178 | 11 August 2022 | | VA Amended Regulations 12VAC5-481 | Cyber Security Brachytherapy |
ML22234A128 | 7 July 2022 | 07001486 | Spectrum Health Hospitals - NRC Form 591M Part 1 & NRC Form 592M, Inspection Report 07001486/2022001 | Brachytherapy Eye plaque |
ML22136A153 | 10 May 2022 | | Wisconsin Subchapter VI 157 59 to 72 Draft | License Renewal Brachytherapy |
ML22063A454 | 26 April 2022 | | IP 87130 Nuclear Medicine Programs | Reactive Inspection |
ML22066A310 | 4 March 2022 | | CRCPD Part T | Exclusive Use Depleted uranium |
ENS 55761 | 1 March 2022 22:15:00 | Ihc Health Services Inc. Dba Intermountain Medical Center | Rb-82 Generator Failure | |
ML22021A339 | 27 January 2022 | | M220127: Slides - Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines | Pandemic COVID-19 Brachytherapy |
VR-SECY-21-0013, SRM-SECY-21-0013: Rulemaking Plan to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies | 13 January 2022 | | SRM-SECY-21-0013: Rulemaking Plan to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies | |
ML22173A148 | 14 December 2021 | 07103091 | Redacted - IS-DS 2651 - Design, Manufacturing and Operating Specification for the F-522 Family of Transport | Liquid penetrant |
ML21326A168 | 22 November 2021 | | Draft Revision 2 of Regulatory Guide 8.39, Release of Patients Administered Radioactive Material, for ACMUI Review | Eye plaque |
ML21301A027 | 25 October 2021 | | Tennessee Regulations 0400-20-07 | License Renewal Brachytherapy |
ML21286A490 | 18 October 2021 | | 10-15-2021 Letter to J.Schuerman Re La Proposed Reg to Rats Ids 2018-1 2020-2 and Other Provisions Not Associated with a Rats Id | Brachytherapy |
ML22173A184 | 20 September 2021 | 07103091 | Redacted - Certificate No. CDN/2094/B(U)-96, Revision 4, Package No. F-522 (Docket No. 71-3091) | Depleted uranium |
ML21193A320 | 7 July 2021 | | Nd Chapter 33.1-10-13.1 | Incorporated by reference Condition Adverse to Quality Uranium Hexafluoride Exclusive Use Depleted uranium |
ML21145A065 | 11 May 2021 | | LTR-21-0145 Laura Thevenot, CEO, American Society for Radiation Oncology, Letter Concern Over the Staffs Recommendation to Initiate Rulemaking to Establish Requirements for rubidium-82 or Rb-82 Generators and Emerging Medical Technologies, | |
ML21104A403 | 14 April 2021 | | Summary of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2021 Meeting, March 16, 2021 | COVID-19 Brachytherapy |
SECY-21-0013, Rulemaking Plan to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies | 9 February 2021 | | SECY-21-0013: Rulemaking Plan to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies | Enforcement Discretion Exemption Request Brachytherapy Backfit TheraSphere |
ML20324A743 | 17 November 2020 | | Comments from State of Wisconsin on the U.S. NRC Draft Secy Paper -Rulemaking Plan to Codify Requirements for Rb-82 Generators and Emergency Medical Technologies (RCPD-20-009) | |
ML20303A306 | 27 October 2020 | | Ks Cross Reference 2015-3, Revisions to Transportation Safety Requirements and Harmonization with International Atomic Energy Agency Transportation Requirements; Including Corrections | Incorporated by reference Depleted uranium |
ML20261H508 | 3 September 2020 | | Nd Regulations 33.1-10-13.1 | Incorporated by reference Condition Adverse to Quality Uranium Hexafluoride Exclusive Use Depleted uranium |
ML20128J890 | 30 June 2020 | | OMB-3150-0010 - Supporting Statement - 10 CFR Part 35 Medical Use of Byproduct Material | Brachytherapy |
NUREG-0090 Volume 42, Report to Congress on Abnormal Occurrences, Fiscal Year 2019 | 30 June 2020 | | NUREG-0090, Vol. 42 Report to Congress on Abnormal Occurrences, Fiscal Year 2019 | Cyber Security Deep Dose Equivalent Brachytherapy Stolen Overexposure Overdose Reactive Inspection |
ML20115E343 | 30 March 2020 | | NRC Staff Medical Event Slides, March 30, 2020, FY19 Events | Brachytherapy TheraSphere Overdose |
ML20115E395 | 30 March 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 30, 2020 Meeting Ebinder, Revised | Brachytherapy Stolen TheraSphere Overexposure Overdose Reactive Inspection |
VR-SECY-20-0018, Report to Congress on Abnormal Occurrences: Fiscal Year 2019 (Caputo) | 27 March 2020 | | VR-SECY-20-0018: Report to Congress on Abnormal Occurrences: Fiscal Year 2019 (Caputo) | Deep Dose Equivalent Brachytherapy Stolen Overexposure Overdose Reactive Inspection |
ML20078M712 | 18 March 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 30, 2020 Meeting Ebinder | Brachytherapy Stolen TheraSphere Overexposure Overdose |
ML20056E123 | 11 March 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 11, 2020 Meeting Ebinder | Brachytherapy |